Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer PatientsG. Ferretti, F. Cognetti, Nello Salesi et al.|Oncology|2005Cited by 133
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive diseasePaola Papaldo, F. Cognetti, Alessandra Fabi et al.|Annals of Oncology|2006Cited by 82
Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?Alessandra Fabi, F. Cognetti, Alessandra Felici et al.|Annals of Oncology|2005Cited by 4